Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $55.1B |
| FY2017, ended Dec 31, 2017 | $76.3B |
| FY2018, ended Dec 31, 2018 | $89.3B |
| FY2019, ended Dec 31, 2019 | $130B |
| FY2020, ended Dec 31, 2020 | $183B |
| FY2021, ended Dec 31, 2021 | $261B |
| FY2022, ended Dec 31, 2022 | $212B |
| FY2023, ended Dec 31, 2023 | $202B |
| FY2024, ended Dec 31, 2024 | $196B |
| FY2025, ended Dec 31, 2025 | $215B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $190B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.3B |
| FY2017, ended Dec 31, 2017 | $20.9B |
| FY2018, ended Dec 31, 2018 | $24.4B |
| FY2019, ended Dec 31, 2019 | $25.5B |
| FY2020, ended Dec 31, 2020 | $32.2B |
| FY2021, ended Dec 31, 2021 | $39.2B |
| FY2022, ended Dec 31, 2022 | $44.9B |
| FY2023, ended Dec 31, 2023 | $42.9B |
| FY2024, ended Dec 31, 2024 | $42.9B |
| FY2025, ended Dec 31, 2025 | $44.6B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $46.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.02B | $2.81B |
| FY2017, ended Dec 31, 2017 | $2.23B | $3.50B |
| FY2018, ended Dec 31, 2018 | $2.94B | $3.79B |
| FY2019, ended Dec 31, 2019 | $3.70B | $4.05B |
| FY2020, ended Dec 31, 2020 | $6.38B | $6.82B |
| FY2021, ended Dec 31, 2021 | $7.72B | $6.79B |
| FY2022, ended Dec 31, 2022 | $6.95B | $6.91B |
| FY2023, ended Dec 31, 2023 | $6.00B | $6.93B |
| FY2024, ended Dec 31, 2024 | $6.33B | $7.27B |
| FY2025, ended Dec 31, 2025 | $6.70B | $6.29B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $6.97B | $7.32B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $786M |
| FY2017, ended Dec 31, 2017 | $1.33B |
| FY2018, ended Dec 31, 2018 | $2.10B |
| FY2019, ended Dec 31, 2019 | $2.40B |
| FY2020, ended Dec 31, 2020 | $10.3B |
| FY2021, ended Dec 31, 2021 | $4.48B |
| FY2022, ended Dec 31, 2022 | $8.52B |
| FY2023, ended Dec 31, 2023 | $8.08B |
| FY2024, ended Dec 31, 2024 | $4.01B |
| FY2025, ended Dec 31, 2025 | $9.85B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $4.06B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.6B |
| FY2017, ended Dec 31, 2017 | $21.0B |
| FY2018, ended Dec 31, 2018 | $19.7B |
| FY2019, ended Dec 31, 2019 | $17.8B |
| FY2020, ended Dec 31, 2020 | $21.7B |
| FY2021, ended Dec 31, 2021 | $34.7B |
| FY2022, ended Dec 31, 2022 | $34.3B |
| FY2023, ended Dec 31, 2023 | $34.7B |
| FY2024, ended Dec 31, 2024 | $31.1B |
| FY2025, ended Dec 31, 2025 | $39.2B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $42.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 390M |
| FY2017, ended Dec 31, 2017 | 402M |
| FY2018, ended Dec 31, 2018 | 399M |
| FY2019, ended Dec 31, 2019 | 399M |
| FY2020, ended Dec 31, 2020 | 394M |
| FY2021, ended Dec 31, 2021 | 391M |
| FY2022, ended Dec 31, 2022 | 385M |
| FY2023, ended Dec 31, 2023 | 381M |
| FY2024, ended Dec 31, 2024 | 377M |
| FY2025, ended Dec 31, 2025 | 371M |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | 370M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.25B | $133M | $0 |
| FY2017, ended Dec 31, 2017 | $750M | $159M | $1.69B |
| FY2018, ended Dec 31, 2018 | $500M | $181M | $0 |
| FY2019, ended Dec 31, 2019 | $1.50B | $181M | $0 |
| FY2020, ended Dec 31, 2020 | $1.50B | $196M | — |
| FY2021, ended Dec 31, 2021 | $2.00B | $230M | — |
| FY2022, ended Dec 31, 2022 | $3.00B | $307M | — |
| FY2023, ended Dec 31, 2023 | $3.00B | $278M | — |
| FY2024, ended Dec 31, 2024 | $4.00B | $301M | — |
| FY2025, ended Dec 31, 2025 | $3.00B | $310M | — |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $5.00B | $319M | — |
Valuation
At current price- Market Cap
- $256B
- P/E
- 36.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.5×
- Price / Book
- 4.9×
- EV / EBITDA
- 26.6×
Growth
Trailing 12 months- Revenue (TTM)
- $46.3B
- Revenue Growth YoY
- 7.2%
- Revenue CAGR 3Y
- −0.3%
- Revenue CAGR 5Y
- 6.7%
- EPS Growth YoY
- 7.5%
- Net Income Growth YoY
- 5.8%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 17.6%
- Net Margin
- 15.0%
- FCF Margin
- 15.8%
- Return on Equity
- 13.5%
Earnings
Trailing 12 months- Net Income
- $6.97B
- EPS (diluted)
- $18.58
- EBITDA
- $11.1B
- Operating Income
- $8.14B
Balance Sheet
As of Jun 27, 2026- Cash and cash equivalents
- $4.06B
- Total Debt
- $42.3B
- Net Debt
- $38.2B
- Total Assets
- $113B
- Total Liabilities
- $60.5B
- Shareholders' Equity
- $52.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.01B
- Capital Expenditure
- $1.70B
- Free Cash Flow
- $7.32B
Dividends and risk
Last 12 months- Dividend Yield
- 0.3%
- Dividend / Share
- $1.84
- Beta (5Y)
- 0.88
Every ratio is calculated from the company’s reported figures.